News
CELZ
1.270
+5.83%
0.070
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 1d ago
Weekly Report: what happened at CELZ last week (0803-0807)?
Weekly Report · 1d ago
Why Avalon Holdings Shares Are Trading Higher By More Than 10%; Here Are 20 Stocks Moving Premarket
Benzinga · 1d ago
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 4d ago
Top Biotech Gainers: CELZ Soars On Patent News, BRVE Debuts Strong, IOVA Revenue Climbs 66%
NASDAQ · 4d ago
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 4d ago
Creative Medical Technology Stock Surges After Key Patent Win
Benzinga · 5d ago
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 5d ago
Creative Medical receives notice of allowance for new U.S. patent
TipRanks · 5d ago
Creative Medical Receives Notice Of Allowance From USPTO For US Patent Application Titled Suppression Of Diabetes Using Exosomes From Stem Cell Programmed Myeloid Cells
Benzinga · 5d ago
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 5d ago
Why SiTime Shares Are Trading Higher By Over 30%; Here Are 20 Stocks Moving Premarket
Benzinga · 5d ago
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 5d ago
Creative Medical Technologies Has Received A Notice Of Allowance For A U.S. Patent Titled "SUPPRESSION OF DIABETES USING EXOSOMES FROM STEM CELL PROGRAMMED MYELOID CELLS"
Benzinga · 5d ago
Weekly Report: what happened at CELZ last week (0727-0731)?
Weekly Report · 08/03 10:02
Weekly Report: what happened at CELZ last week (0720-0724)?
Weekly Report · 07/27 10:06
Creative Medical files to sell 5.58M shares of common stock for holders
TipRanks · 07/24 20:10
Weekly Report: what happened at CELZ last week (0713-0717)?
Weekly Report · 07/20 10:03
Weekly Report: what happened at CELZ last week (0706-0710)?
Weekly Report · 07/13 10:04
Creative Medical Technology Holdings (CELZ) Receives a Buy from Roth MKM
TipRanks · 07/06 13:25
More
Webull provides a variety of real-time CELZ stock news. You can receive the latest news about Creative Med Technology Hldgs through multiple platforms. This information may help you make smarter investment decisions.
About CELZ
Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company dedicated to the advancement of identifying and translating novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology and orthopedics. The Company conducts substantially all of its commercial operations through its subsidiary, Creative Medical Technologies, Inc. Its products include AlloStem (CELZ-201-DDT) - allogenic human perinatal tissue derived cell program (clinical phase), ImmCelz (CELZ-100) - personalized supercharged immune therapy platform (pre-clinical trials), Type I Diabetes (CELZ-201 CREATE-1) - type I diabetes, Allostemspine Chronic Lower Back Pain (CELZ 201 ADAPT), Alova, CaverStem - erectile dysfunction treatment, FemCelz - female sexual function treatment, StemSpine - regenerative stem cell procedure for the treatment of degenerative disc disease (clinical trials), and OvaStem - stem cell therapy for premature ovarian failure.